Estimation application downloads and cost
Description
A quick pocket tool to help medical professionals assess and treat albuminuria in people with diabetes and other high risk patients. Designed for rapid, convenient, point-of-care intervention whenever and wherever you need it. Content is adapted from KDOQI evidence-based clinical practice guidelines and recommendations from the National Kidney Foundation.
Features:
Designed for rapid, convenient, point-of-care intervention. With a few quick taps, you will:
•Evaluate diabetic patients for albuminuria and chronic kidney disease (CKD)
•Use evidence-based strategies to assess and treat
•Access an interactive, clinical action plan that can be individualized for your patients
Simple, quick, and organized by:
•What is Albuminuria?
•Why screen for albuminuria in high risk patients?
•When to screen
•How to screen
•Follow-up using a simple, interactive decision-making algorithm
•Facts about albuminuria, diabetes, and chronic kidney disease
Facts About Chronic Kidney Disease
•Kidney disease is common, harmful, and treatable.
•26 million Americans have kidney disease – but most do not know they have it. Millions more are at increased risk.
•High risk groups include those with diabetes, hypertension, and a family history of kidney disease. Blacks, Hispanics, Asians, Pacific Islanders, American Indians, and seniors are also at increased risk.
•Early detection can slow the progression of kidney disease.
•Once kidneys fail, patients need dialysis or a transplant to survive.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention, and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk.
By supporting the National Kidney Foundation, you directly influence and positively impact the lives of those at risk for kidney disease, those living with chronic kidney disease, and those who care for and about them.
Learn more at www.kidney.org
30 East 33rd Street
New York, NY 10016
www.kidney.org
800-622-9010
Read more
Features:
Designed for rapid, convenient, point-of-care intervention. With a few quick taps, you will:
•Evaluate diabetic patients for albuminuria and chronic kidney disease (CKD)
•Use evidence-based strategies to assess and treat
•Access an interactive, clinical action plan that can be individualized for your patients
Simple, quick, and organized by:
•What is Albuminuria?
•Why screen for albuminuria in high risk patients?
•When to screen
•How to screen
•Follow-up using a simple, interactive decision-making algorithm
•Facts about albuminuria, diabetes, and chronic kidney disease
Facts About Chronic Kidney Disease
•Kidney disease is common, harmful, and treatable.
•26 million Americans have kidney disease – but most do not know they have it. Millions more are at increased risk.
•High risk groups include those with diabetes, hypertension, and a family history of kidney disease. Blacks, Hispanics, Asians, Pacific Islanders, American Indians, and seniors are also at increased risk.
•Early detection can slow the progression of kidney disease.
•Once kidneys fail, patients need dialysis or a transplant to survive.
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention, and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families, and tens of millions of Americans at risk.
By supporting the National Kidney Foundation, you directly influence and positively impact the lives of those at risk for kidney disease, those living with chronic kidney disease, and those who care for and about them.
Learn more at www.kidney.org
30 East 33rd Street
New York, NY 10016
www.kidney.org
800-622-9010
Screening for Albuminuria in Patients with Diabetes screenshorts
ASO analyse Screening for Albuminuria in Patients with Diabetes app for iPhone and iPad
| # | Term | Store county | Place | Priority |
|---|---|---|---|---|
| 1 | diabetes @point of care™ | 4 | ⭐️⭐️⭐️⭐️ |
Competitors of Screening for Albuminuria in Patients with Diabetes application
| # | App | Common words |
|---|---|---|
| 1 | Diabetes @Point of Care™ | 13 |
| 2 | Diabetes Health Manager | 13 |
| 3 | Johns Hopkins Antibiotic Guide | 9 |
Application availability
Available in countries
| Country | Price |
|---|---|
| Canada | free |
| China | free |
| France | free |
| Germany | free |
| Italy | free |
| Netherlands | free |
| Portugal | free |
| Spain | free |
| Poland | free |
| UK | free |
| India | free |
| Japan | free |
| Korea, Republic Of | free |
| Poland | free |
| Russia | free |
| Turkey | free |
| USA | free |
| Korea, Republic Of | free |
| Ukraine | free |
Available for devices
iPhone3GS, iPhone4, iPodTouchFourthGen, iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX, iPad75, iPad76, iPhoneXS, iPhoneXSMax, iPhoneXR, iPad812, iPad834, iPad856, iPad878, Watch4, iPadMini5, iPadMini5Cellular, iPadAir3, iPadAir3Cellular, iPodTouchSeventhGen, iPhone11, iPhone11Pro, Watch5, iPadSeventhGen, iPadSeventhGenCellular, iPhone11ProMax, iPhoneSESecondGen, iPadProSecondGen, iPadProSecondGenCellular, iPadProFourthGen, iPadProFourthGenCellular,Other apps from National Kidney Foundation
Similar apps
